Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus glycosidase inhibitors in newly diagnosed overweight or obese type 2 diabetes
ChiCTR-TRC-11001808Phase 4Completed
- Sponsor
- Xiangtan Central Hospital
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Xiangtan Central Hospital. Primary endpoints: insulin, glucagon and 3 more. Started Feb 2010; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-11001808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001808.